• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[间歇性腹膜透析期间腹腔内活性肝素丢失的评估]

[Evaluation of loss of active heparin in the peritoneal cavity during intermittent peritoneal dialysis].

作者信息

Kuźniak J, Grzegorzewska A

机构信息

Zakładu Analityki Medycznej Katedry Onkologii AM.

出版信息

Pol Tyg Lek. 1992;47(5-6):123-5.

PMID:1437798
Abstract

Our studies aimed at determining a loss of active heparin from the peritoneal cavity after its intraperitoneal administration (250 JU/l of dialysis fluid) in 16 patients treated because of the end-stage renal failure with intermittent peritoneal dialysis and at comparing heparin influx clearance with that of glucose. It has been shown that heparin used in this dose loses 60-70% of its activity after 20-minute equilibration of dialysis fluid in the peritoneal cavity. Heparin influx clearance is higher than that of glucose but it depends on utilization of heparin in peritoneal cavity rather than on its penetration to the blood circulation.

摘要

我们的研究旨在确定16例因终末期肾衰竭接受间歇性腹膜透析治疗的患者腹腔内注射肝素(250国际单位/升透析液)后,腹腔内活性肝素的损失情况,并将肝素流入清除率与葡萄糖的流入清除率进行比较。结果表明,以该剂量使用的肝素在腹腔内透析液平衡20分钟后,其活性损失60%-70%。肝素流入清除率高于葡萄糖,但它取决于肝素在腹腔内的利用情况,而非其向血液循环的渗透情况。

相似文献

1
[Evaluation of loss of active heparin in the peritoneal cavity during intermittent peritoneal dialysis].[间歇性腹膜透析期间腹腔内活性肝素丢失的评估]
Pol Tyg Lek. 1992;47(5-6):123-5.
2
[Effect of sulfinpyrazone on peritoneal and renal clearance in patients with chronic renal failure treated by intermittent peritoneal dialysis].[磺吡酮对接受间歇性腹膜透析治疗的慢性肾衰竭患者腹膜及肾脏清除率的影响]
Przegl Lek. 1990;47(10):686-90.
3
[Peritoneal equilibration test].[腹膜平衡试验]
Harefuah. 1990 Mar 15;118(6):312-5.
4
[Effectiveness of peritoneal dialysis using dialysis fluid of modernized composition].[使用现代化成分透析液进行腹膜透析的有效性]
Wiad Lek. 1990 Jun 15;43(12):564-71.
5
Activity of intraperitoneal heparin during peritoneal dialysis.腹膜透析期间腹腔内肝素的活性
Clin Nephrol. 1978 Jan;9(1):15-8.
6
Methotrexate clearance by high-flux hemodialysis and peritoneal dialysis: a case report.高通量血液透析和腹膜透析清除甲氨蝶呤:一例报告
Am J Kidney Dis. 2009 May;53(5):871-4. doi: 10.1053/j.ajkd.2009.01.016. Epub 2009 Apr 1.
7
[Levels of plasma proteins in patients with ene stage renal failure treated with peritoneal dialysis with an addition of furosemide to dialysis fluid].[在透析液中添加呋塞米进行腹膜透析治疗的终末期肾衰竭患者的血浆蛋白水平]
Pol Tyg Lek. 1994;49(6-7):137-40.
8
Vancomycin pharmacokinetics in patients undergoing chronic intermittent peritoneal dialysis.慢性间歇性腹膜透析患者的万古霉素药代动力学
Int J Clin Pharmacol Ther Toxicol. 1982 Dec;20(12):559-63.
9
Peroxidase activity in peritoneal neutrophils of patients with terminal renal failure treated by intermittent peritoneal dialysis.接受间歇性腹膜透析治疗的终末期肾衰竭患者腹膜中性粒细胞中的过氧化物酶活性
Med Interne. 1990 Apr-Jun;28(2):135-8.
10
[Effect of intraperitoneal furosemide administration on levels of +proteins+ in plasma and signs of their ability to be dialyzed during intermittent peritoneal dialysis].[腹腔注射速尿对间歇性腹膜透析期间血浆中蛋白质水平及其可透析能力指标的影响]
Pol Tyg Lek. 1991;46(4-5):67-70.